Literature DB >> 9401759

Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.

S Hishinuma1, I Hongo, Y Matsumoto, F Narita, M Kurokawa.   

Abstract

1. We compared the binding profiles and contractile mechanisms of putative muscarinic M1 agonists McN-A-343 and AHR-602 with those of carbachol in smooth muscle of guinea-pig taenia caeci. 2. McN-A-343 and AHR-602, as well as carbachol, completely displaced the atropine-sensitive binding of [3H]-quinuclidinyl benzilate to muscarinic receptors present in the membrane preparation. The potency order for the affinity of these agents for muscarinic receptors was carbachol > McN-A-343 >> AHR-602. 3. In the presence of 2.2 mM extracellular Ca2+, McN-A-343 and AHR-602 induced contraction corresponding to 79 and 85%, respectively, of the maximal contraction to 0.1 mM carbachol. Contractions induced by these agents were mediated via activation of the muscarinic receptor subtype that had a high affinity for 4-DAMP (M3 selective) but a low affinity for pirenzepine (M1 selective) and AF-DX 116 (M2 selective). These contractions were inhibited by an L-type Ca2+ channel blocker, verapamil. 4. In Ca(2+)-free solution containing 2 mM EGTA, carbachol elicited a transient contraction whereas no contraction was observed in response to McN-A-343 and AHR-602. Application of McN-A-343 or AHR-602 inhibited the carbachol-induced contraction in Ca(2+)-free solution, and this inhibition was surmounted by a higher concentration of carbachol. 5. The EC50 value for carbachol-induced contraction in the presence of extracellular Ca2+ was approximately 175 times lower than that in the absence of Ca2+. After treatment with propylbenzilylcholine mustard, carbachol induced contraction only in the presence of extracellular Ca2+. 6. The results suggest that in the taenia caeci there is a greater receptor reserve for muscarinic M3 receptor-mediated Ca2+ influx than for M3 mediated Ca2+ release. The compounds McN-A-343 and AHR-602 are agonists of the Ca2+ influx pathway, but do not appear to stimulate the Ca2+ release pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401759      PMCID: PMC1565030          DOI: 10.1038/sj.bjp.0701467

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Muscarinic agonist potencies at three different effector systems linked to the M(2) or M(3) receptor in longitudinal smooth muscle of guinea-pig small intestine.

Authors:  H Okamoto; S A Prestwich; S Asai; T Unno; T B Bolton; S Komori
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice.

Authors:  Toshihiro Unno; Hayato Matsuyama; Takashi Sakamoto; Mai Uchiyama; Yusuke Izumi; Hiroyuki Okamoto; Masahisa Yamada; Jürgen Wess; Seiichi Komori
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Roles of M2 and M3 muscarinic receptors in cholinergic nerve-induced contractions in mouse ileum studied with receptor knockout mice.

Authors:  T Unno; H Matsuyama; Y Izumi; M Yamada; J Wess; S Komori
Journal:  Br J Pharmacol       Date:  2006-11-13       Impact factor: 8.739

4.  Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.

Authors:  Darla Karpinsky-Semper; Claude-Henry Volmar; Shaun P Brothers; Vladlen Z Slepak
Journal:  Mol Pharmacol       Date:  2014-02-28       Impact factor: 4.436

5.  Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.

Authors:  T Unno; S-C Kwon; H Okamoto; Y Irie; Y Kato; H Matsuyama; S Komori
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.